What disease does bosentan treat?
Bosentan is a treatment drug specifically for pulmonary arterial hypertension (PAH). Pulmonary hypertension is a rare but serious disease that seriously affects the quality of life and life expectancy of patients. Its main feature is that the pressure in the pulmonary arteries continues to increase, resulting in increased burden on the heart, which may eventually lead to right heart failure or even death.
Bosentan belongs to the endothelin receptor antagonist category and blocks the effects of endothelin by specifically binding to endothelin receptors. Endothelin is a powerful vasoconstrictor and cell proliferation factor that is closely related to the occurrence and development of pulmonary hypertension. Bosentan can reduce endothelin-mediated vasoconstriction and vascular smooth muscle cell proliferation, thereby reducing pulmonary artery pressure and pulmonary vascular resistance and improving cardiac function.
Clinically, bosentan is widely used in patients with various types of pulmonary hypertension, including idiopathic pulmonary hypertension, connective tissue disease-related pulmonary hypertension, and congenital heart disease-related pulmonary hypertension. It can not only relieve patients' symptoms, such as dyspnea, fatigue and syncope, but also improve patients' quality of life and extend survival time.
However, bosentan is not without side effects. Patients may experience some adverse reactions when using bosentan, such as abnormal liver function, fluid retention, anemia, etc. Therefore, before using bosentan, doctors will conduct a comprehensive evaluation of the patient, including physical examination, blood tests, and imaging tests, to ensure that the patient is suitable for the drug. During the medication process, doctors will also regularly monitor the patient's liver function, blood indicators, pulmonary artery pressure and other indicators in order to adjust the treatment plan in a timely manner to ensure the patient's safety.
In short, bosentan is a therapeutic drug specifically targeted at pulmonary hypertension. It reduces pulmonary artery pressure and pulmonary vascular resistance and improves heart function by blocking the action of endothelin. However, when using bosentan, you need to pay attention to its possible side effects and contraindications, and carry out individualized treatment under the guidance of a doctor.
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)